IL18RAP and systemic lupus erythematosus: As shown in Figure 2D,E, higher IL18RAP expression was observed in SLE patients exhibiting active manifestations of the renal system (presence of urinary casts, haematuria, proteinuria, or pyuria—as defined by the descriptors in the SLEDAI-2K scoring system) and the immunological system (low complement or increased DNA binding).